
Drug Target Models
GPCR Reporter Cells
Immunotherapy cells
Other Stable Cells
Assay Kits & Reagents
Services
Resources
Company
Cat. No: RQP74609
Size: 1 vial of frozen cells (>1E6 per vial in 1 mL)
Unit Price: Contact For Pricing
Interleukin-23 (IL-23) is a key pro-inflammatory cytokine in the pathogenesis of chronic inflammatory diseases—such as psoriasis, inflammatory bowel disease, multiple sclerosis, and rheumatoid arthritis—and belongs to the IL-12 family, alongside IL-12, IL-27, IL-35, and IL-39. The pathological consequences of excessive IL-23 signaling stem from its ability to stimulate target cell populations (primarily Th17 cells and IL-17-secreting TCRγδ cells, or Tγδ17 cells) to produce inflammatory mediators such as IL-17, IL-22, granulocyte-macrophage colony-stimulating factor (GM-CSF), and tumor necrosis factor-alpha (TNF-α). These pathogenic mediators promote the recruitment and activation of granulocytes and macrophages, leading to tissue damage, the induction of chronic inflammation, and the eventual development of clinical symptoms.
IL-23 is a heterodimeric cytokine composed of two subunits—p40 (encoded by *IL12B*) and p19 (*IL23A*)—linked by a disulfide bond; it binds to a membrane receptor complex formed by IL-12Rβ1 and the unique IL-23R. IL-23 shares the p40 subunit and one receptor component, IL-12Rβ1, with IL-12. Despite sharing these subunits, IL-23 and IL-12 possess distinct biological functions. IL-23 stimulates JAK2 and TYK2 activity, resulting in the activation of signal transducer and activator of transcription (STAT) proteins.
| Cat. No | RQP74609 |
| Product Name | HEK293 Human IL23R&IL12RB1 Cell |
| Culture Properties | Adherent |
| Stability | 32passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Mycoplasma Status | Negative |
| Culture Medium | DMEM+10%FBS+2 μg/ml Puromycin +5 μg/ml Blasticidin |
| Freeze Medium | 90% FBS+10% DMSO |
| Storage Conditions | Liquid nitrogen immediately upon delivery |
| Application | Binding Assay,FACS |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.

Figure 1. Recombinant HEK293 Human IL23R&IL12RB1 Cell stably expressing IL12RB1&IL23R.
Cell Resuscitation
1)Rapidly thaw the frozen cells in a 37 °C water bath for approximately 60 seconds. Once thawed (which may take slightly less or more than 60 seconds), immediately transfer the cell suspension from the cryovial into a 15 mL centrifuge tube containing 10 mL of pre-warmed HEK293 Human IL23R&IL12RB1 Cell complete culture medium.
2)Centrifuge cells at 1000 rpm for 5 min to remove medium, then resuspend cells in 5 mL of pre-warmed complete medium.
3)Transfer the cell suspension into a T25 culture flask and incubate at 37 °C with 5% CO₂.
4)After approximately 24–36 hours, replace the medium or passage the cells to remove non-adherent dead cells.
Subculturing procedure
1)When the cell density reaches the appropriate confluency for passaging, wash the cells with PBS, then add 1 mL trypsin to detach the cells. When more than 80% of the cells detach upon gently tapping the culture flask, add complete culture medium to terminate digestion. Gently pipette to obtain a single-cell suspension, transfer to a 15 mL centrifuge tube, and centrifuge at 1000 rpm for 5 minutes.
2)Discard supernatant after centrifugation. Resuspend cells in fresh medium to a single-cell suspension and transfer to a new culture flask for continued growth.
Cell Freezing
After trypsinization and centrifugation of cells from each T75 flask or 10 cm culture dish, discard the supernatant. Add 2 mL of cryopreservation medium (90% FBS + 10% DMSO), gently resuspend thoroughly, and aliquot into two cryovials. Immediately place the cryovials into a controlled-rate freezing container (e.g., Nalgene 5100-0001), fill with isopropanol to the indicated level, and store at −80 °C. After 24 hours, transfer the cryovials to liquid nitrogen for long-term storage.
We Are Pleased to Announce: Global Commercial Licensing Rights for Jurkat E6.1, CHO-K1, HEK293, THP-1 and RAJI Cell Lines Officially Secured.
ExploreWe Are Pleased to Announce: Global Commercial Licensing Rights for Jurkat E6.1, CHO-K1, HEK293, THP-1 and RAJI Cell Lines Officially Secured.
Explore